Study: High-Dose FXI-ASO Superior to Enoxaparin for VTE Prevention Post-Surgery - MPR

Study: High-Dose FXI-ASO Superior to Enoxaparin for VTE Prevention Post-Surgery - MPR

瀏覽:1234
日期:2024-08-04
(HealthDay News) — Reducing factor XI levels with a second-generation antisense oligonucleotide (FXI-ASO) is effective for preventing venous thromboembolism after total knee arthroplasty, according to a study published online December 7 in the New England...看更多